Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FEGTU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $42,773
Award facts
- Contract value 100% obligated
- $42,772.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $42,772.73 to AmerisourceBergen Drug Corp for the supply of Zepbound (tirzepatide) 10 mg/0.5 mL pens on August 25, 2025. This firm fixed-price delivery order, which represents a non-competitive set-aside transaction, is scheduled for completion by August 26, 2025, and will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, was selected through competitive processes to fulfill this delivery order supporting military healthcare supply requirements. The company's established IDC with DLA positions it to respond to specific medical supply needs across the Defense Health Agency and other government healthcare systems. This award represents a single delivery order transaction within the broader pharmaceutical prime vendor framework that DLA maintains to ensure consistent access to brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains for the military health system.
Quick answers
Who was awarded contract SPE2DB25FEGTU?
SPE2DB25FEGTU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 25, 2025.
How much is contract SPE2DB25FEGTU worth?
The government has obligated $42,773 on SPE2DB25FEGTU.
Is contract SPE2DB25FEGTU an order under another contract?
Yes. SPE2DB25FEGTU is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB25FEGTU competed?
The extent of competition for SPE2DB25FEGTU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award